Hemlibra — Highmark
Hemophilia A
Initial criteria
- Diagnosis of Hemophilia A (ICD-10: D66)
- Using the product for routine prophylaxis
Reauthorization criteria
- Prescriber attests member is tolerating therapy and has experienced a therapeutic response defined as disease stability, disease improvement, or delayed disease progression
Approval duration
12 months